[Clinical aspects of the administration of gestagen preparations (Volidan, Cyclofarlutal, Ovulen, Ciba AC-101 and Steridil)].
D000328:Adult; D003276:Contraceptives, Oral / Q000009:adverse effects; D003516:Cycloparaffins / Q000494:pharmacology; D004357:Drug Synergism; D004997:Ethinyl Estradiol; D005040:Ethynodiol Diacetate; D005260:Female; D006801:Humans; D008234:Lynestrenol; D008525:Medroxyprogesterone; D008535:Megestrol; D008656:Mestranol; D011247:Pregnancy; D011278:Pregnanes / Q000494:pharmacology; D013997:Time Factors
D003276:Contraceptives, Oral; D003516:Cycloparaffins; D011278:Pregnanes; D004997:Ethinyl Estradiol; D005040:Ethynodiol Diacetate; D008656:Mestranol; D008535:Megestrol; D008525:Medroxyprogesterone; D008234:Lynestrenol
Kliniczne aspekty stosowania preparatow (volidan, cyclofarluta, ovulen, ciba AC-101 i stediril)